Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1475-1485
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1475
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1475
Group | n | CEA (ng/mL) | CA199 (U/mL) | CA724 (U/mL) |
Gastric cancer stage I group | 20 | 18.05 ± 4.16 | 46.31 ± 6.78 | 34.29 ± 5.46 |
Gastric cancer stage II group | 23 | 21.43 ± 4.22a | 50.25 ± 5.27a | 39.41 ± 5.89a |
Gastric cancer stage III group | 28 | 25.58 ± 5.37a,b | 54.33 ± 7.64a,b | 43.68 ± 6.03a,b |
Gastric cancer stage IV group | 16 | 30.68 ± 4.83a,b,c | 61.63 ± 8.11a,b,c | 48.72 ± 6.95a,b,c |
F value | 29.482 | 21.709 | 25.139 | |
P value | < 0.001 | < 0.001 | < 0.001 |
- Citation: Wang R, Zuo CL, Zhang R, Zhu LM. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis. World J Gastrointest Oncol 2023; 15(8): 1475-1485
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1475.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1475